Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project.
Masaya HattoriVictoria Serelli-LeeYoichi NaitoTakashi YamanakaHiroyuki YasojimaRikiya NakamuraTakao FujisawaMitsuho ImaiYoshiaki NakamuraHideaki BandoTsutomu KawaguchiTakayuki YoshinoHiroji IwataPublished in: JCO precision oncology (2024)
hotspot mutations in abemaciclib-treated patients with HR+/HER2- MBC. The data provide insights that could help optimize treatment strategies in this population.
Keyphrases
- circulating tumor
- epidermal growth factor receptor
- metastatic breast cancer
- cell free
- circulating tumor cells
- electronic health record
- tyrosine kinase
- advanced non small cell lung cancer
- endothelial cells
- big data
- papillary thyroid
- quality improvement
- newly diagnosed
- squamous cell
- copy number
- induced pluripotent stem cells
- pluripotent stem cells
- machine learning
- childhood cancer